Terms: = Liver cancer AND DDX6, P54, 1656, ENSG00000110367, HLR2, P26196, RCK, FLJ36338 AND Treatment
6 results:
1. Nuclear scaffold protein p54
Shen M; Zhang R; Jia W; Zhu Z; Zhao X; Zhao L; Huang G; Liu J
Oncogene; 2021 Jun; 40(24):4167-4183. PubMed ID: 34079086
[TBL] [Abstract] [Full Text] [Related]
2. Are we reproducible in measurement of NET liver metastasis?
Moalla S; Arfi Rouche J; Foulon S; Caramella C; Ternes N; Planchard D; Goere D; Ducreux M; Scoazec JY; Deschamps F; Dromain C; Baudin E
Dig Liver Dis; 2017 Oct; 49(10):1121-1127. PubMed ID: 28844707
[TBL] [Abstract] [Full Text] [Related]
3. Five-year survival of patients with hepatocellular carcinoma treated with laparoscopic microwave coagulation therapy.
Seki S; Sakaguchi H; Iwai S; Kadoya H; Kabayashi S; Kitada T; Fujii H; Tanaka T
Endoscopy; 2005 Dec; 37(12):1220-5. PubMed ID: 16329021
[TBL] [Abstract] [Full Text] [Related]
4. Medullary thyroid carcinoma in Hong Kong Chinese patients.
Chow SM; Chan JK; Tiu SC; Choi KL; Tang DL; Law SC
Hong Kong Med J; 2005 Aug; 11(4):251-8. PubMed ID: 16085941
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of a DEAD box/RNA helicase protein, rck/p54, in human hepatocytes from patients with hepatitis C virus-related chronic hepatitis and its implication in hepatocellular carcinogenesis.
Miyaji K; Nakagawa Y; Matsumoto K; Yoshida H; Morikawa H; Hongou Y; Arisaka Y; Kojima H; Inoue T; Hirata I; Katsu K; Akao Y
J Viral Hepat; 2003 Jul; 10(4):241-8. PubMed ID: 12823589
[TBL] [Abstract] [Full Text] [Related]
6. Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer. A randomized clinical trial.
Gasparini G; Dal Fior S; Panizzoni GA; Favretto S; Pozza F
Am J Clin Oncol; 1991 Feb; 14(1):38-44. PubMed ID: 1987737
[TBL] [Abstract] [Full Text] [Related]
